In our study, the Western blot results showed that compared with the control group, the expression of CCN1 increased significantly from the early to the advanced stage of PAH, and over time, the increase of CCN1 showed a downward trend, but it was still higher than that in the control group. Here, CCN1 is linked to pulmonary arterial hypertension.